Rein Therapeutics (RNTX) news

Recent news

Rein Therapeutics Inc gets FDA fast track designation

AInvest Wire · Aug 20, 2026

Rein Therapeutics Inc. <RNTX.O>: H.C. Wainwright cuts target price to $8 from $10

H.C. Wainwright has revised its price target for Rein Therapeutics Inc. (RNTX.O), reducing it to $8 from $10, while maintaining a Buy rating. The adjustment reflects the firm’s reassessment of the company’s near-term financial trajectory and market dynamics. Rein Therapeutics, a biopharmaceutical…

AInvest Wire · Jun 1, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by